1 |
Zimmer S, Kolbe C, Kaiser G, Krage T, Ommerborn M, Barthel C. Clinical efficacy of flossing versus use of antimicrobial rinses. J Periodontol 2006;77:1380-5.
DOI
|
2 |
Mankodi S, Bauroth K, Witt JJ, Bsoul S, He T, Gibb R, et al. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Am J Dent 2005;18 Spec No:9A-14A.
|
3 |
Allen DR, Davies R, Bradshaw B, Ellwood R, Simone AJ, Robinson R, et al. Efficacy of a mouthrinse containing 0.05% cetylpyridinium chloride for the control of plaque and gingivitis: a 6-month clinical study in adults. Compend Contin Educ Dent 1998;19(2 Suppl):20-6.
|
4 |
Nelson RF, Rodasti PC, Tichnor A, Lio YL. Comparative study of four over-the-counter mouthrinses claiming antiplaque and/or antigingivitis benefits. Clin Prev Dent 1991; 13:30-3.
|
5 |
Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 2004;31:878-84.
DOI
|
6 |
Herrera D, Santos S, Ferrus J, Barbieri G, Trombelli L, Sanz M. Efficacy of a 0.15% benzydamine hydrochloride and 0.05% cetylpyridinium chloride mouth rinse on 4-day de novo plaque formation. J Clin Periodontol 2005;32:595-603.
DOI
|
7 |
Quirynen M, Soers C, Desnyder M, Dekeyser C, Pauwels M, van Steenberghe D. A 0.05% cetyl pyridinium chloride/ 0.05% chlorhexidine mouth rinse during maintenance phase after initial periodontal therapy. J Clin Periodontol 2005;32:390-400.
DOI
|
8 |
Mandel ID. Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol 1988;15:488-98.
DOI
|
9 |
Jorgensen MG, Slots J. Antimicrobials in periodontal maintenance. J Dent Hyg 2001;75:233-9.
|
10 |
Wu CD, Savitt ED. Evaluation of the safety and efficacy of over-the-counter oral hygiene products for the reduction and control of plaque and gingivitis. Periodontol 2000 2002; 28:91-105.
DOI
|
11 |
Lang NP, Catalanotto FA, Knopfli RU, Antczak AA. Quality-specific taste impairment following the application of chlorhexidine digluconate mouthrinses. J Clin Periodontol 1988; 15:43-8.
DOI
|
12 |
Pitten FA, Kramer A. Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic. Arzneimittelforschung 2001;51:588-95.
|
13 |
Silva MF, dos Santos NB, Stewart B, DeVizio W, Proskin HM. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis. J Clin Dent 2009;20:55-61.
|
14 |
Gaffar A, Afflitto J, Nabi N, Herles S, Kruger I, Olsen S. Recent advances in plaque, gingivitis, tartar and caries prevention technology. Int Dent J 1994;44(1 Suppl 1):63-70.
|
15 |
Wu X, Zhang T, Zhang Y. Effect of a new triclosan-containing mouth rinse on oral infection. Zhonghua Kou Qiang Yi Xue Za Zhi 2001;36:301-3.
|
16 |
Zuckerbraun HL, Babich H, May R, Sinensky MC. Triclosan: cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci 1998;106 (2 Pt 1):628-36.
DOI
|
17 |
Loe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:Suppl:610-6.
DOI
|
18 |
Masatake T, Hidekazu K, Yasuhiko A, Toshiyuki T, Akira S, Toshio H, et al. The clinical evaluation of mouth rinse for periodontal disease. Jpn J Conserv Dent 2000;43:703-11.
|
19 |
Fischman SL. Clinical index systems used to assess the efficacy of mouthrinses on plaque and gingivitis. J Clin Periodontol 1988;15:506-10.
DOI
|
20 |
Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-51.
DOI
|
21 |
Axelsson P, Lindhe J. Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. J Clin Periodontol 1987;14:205-12.
DOI
|
22 |
Engelberger T, Hefti A, Kallenberger A, Rateitschak KH. Correlations among Papilla Bleeding Index, other clinical indices and histologically determined inflammation of gingival papilla. J Clin Periodontol 1983;10:579-89.
DOI
|
23 |
Slots J, Rams TE. New views on periodontal microbiota in special patient categories. J Clin Periodontol 1991;18:411-20.
DOI
|
24 |
Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992;63(4 Suppl):322-31.
DOI
|
25 |
Quirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H. Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. J Dent Res 1995;74:1459-67.
DOI
|
26 |
Becker W, Becker BE, Berg LE. Periodontal treatment without maintenance. A retrospective study in 44 patients. J Periodontol 1984;55:505-9.
DOI
|
27 |
DePaola LG, Minah GE, Overholser CD, Meiller TF, Charles CH, Harper DS, et al. Effect of an antiseptic mouthrinse on salivary microbiota. Am J Dent 1996;9:93-5.
|
28 |
Lindhe J, Westfelt E, Nyman S, Socransky SS, Haffajee AD. Long-term effect of surgical/non-surgical treatment of periodontal disease. J Clin Periodontol 1984;11:448-58.
DOI
|
29 |
Escribano M, Herrera D, Morante S, Teughels W, Quirynen M, Sanz M. Efficacy of a low-concentration chlorhexidine mouth rinse in non-compliant periodontitis patients attending a supportive periodontal care programme: a randomized clinical trial. J Clin Periodontol 2010;37:266-75.
DOI
|